A Study of the Influence of Sex on Genome Wide Methylation by Liu, Jingyu et al.
A Study of the Influence of Sex on Genome Wide
Methylation
Jingyu Liu
1,2*, Marilee Morgan
1, Kent Hutchison
1,3, Vince D. Calhoun
1,2
1The Mind Research Network, Albuquerque, New Mexico, United States of America, 2Department of Electrical and Computer Engineering, University of New Mexico,
Albuquerque, New Mexico, United States of America, 3Department of Psychology, University of New Mexico, Albuquerque, New Mexico, United States of America
Abstract
Sex differences in methylation status have been observed in specific gene-disease studies and healthy methylation variation
studies, but little work has been done to study the impact of sex on methylation at the genome wide locus-to-locus level or
to determine methods for accounting for sex in genomic association studies. In this study we investigate the genomic sex
effect on saliva DNA methylation of 197 subjects (54 females) using 20,493 CpG sites. Three methods, two-sample T-test,
principle component analysis and independent component analysis, all successfully identify sex influences. The results show
that sex not only influences the methylation of genes in the X chromosome but also in autosomes. 580 autosomal sites
show strong differences between males and females. They are found to be highly involved in eight functional groups,
including DNA transcription, RNA splicing, membrane, etc. Equally important is that we identify some methylation sites
associated with not only sex, but also other phenotypes (age, smoking and drinking level, and cancer). Verification was done
through an independent blood cell DNA methylation data (1298 CpG sites from a cancer panel array). The same genomic
site-specific influence pattern and potential confounding effects with cancer were observed. The overlapping rate of
identified sex affected genes between saliva and blood cell is 81% for X chromosome, and 8% for autosomes. Therefore,
correction for sex is necessary. We propose a simple correction method based on independent component analysis, which is
a data driven method and accommodates sample differences. Comparison before and after the correction suggests that the
method is able to effectively remove the potentially confounding effects of sex, and leave other phenotypes untouched. As
such, our method is able to disentangle the sex influence on a genome wide level, and paves the way to achieve more
accurate association analyses in genome wide methylation studies.
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Introduction
DNA methylation occurs on the C5 position (the 5
th carbon of
the cytosine pyrimidine ring) of CpG dinucleotides along the DNA
chain, and forms one of the epigenetic mechanisms controlling
and modulating gene expression. It is not only essential for normal
cellular development, but also may be associated with formation of
diseases. Cancer, for example, has been related to genome-wide
hypomethylation coinciding with gene specific hypermethylation
[1]. A few new studies also show that methylation change of
specific genes is associated with mental illness, such as hypo-
methylation of MB-COMT in schizophrenic and bipolar disorder
patients [2,3,4,5].
In addition to disease, inter-individual differences in healthy
subjects are also observed and are influenced by factors like age,
sex and tissue type [6]. Sex differences have been discussed with
contradictory results. Eckhardt et al. [7] studied 2,524 loci on
chromosome 6, 20 and 22 in 12 different tissues in 43 samples, and
could not find any statistical difference between male and female
samples. In contrast, Sarter et al. reported significant sex
differences in four autosomal genes, and suggested that sex is at
least as strong a predictor of methylation in certain genes as age
[8]. Moreover, conflicting results have been drawn regarding
whether females or males have higher methylation levels. A
tendency toward higher methylation levels in males was identified
in three regions at PEG3, NESP55 (GNAS) and H19 imprinted
genes and two additional loci at Xq28 (F8 gene) and at 19q13.4 [9].
Expression level of DNMT3b (a DNA methyltransferase) in human
liver is significantly higher in females than males, which potentially
influences DNA methylation status [10]. In methylation-disease
studies, females are shown to be 8.8 time more likely than males to
have methylation positive colorectal cancer [11]. Though sex
effects appear to differ across studies, no single study so far has
focused on the sex effect across the genome.
With the microarray genotyping technique, genome wide
methylation measurements are available with up to over 27,578
genetic sites covering 23 pairs of chromosomes (Illumina Infinium
Methylation Assay). Such technology will surely lead to genome
wide association studies (GWAS) of methylation on various
phenotypes. To date, more GWAS have been done on single
nucleotide polymorphisms [12] than on methylation. Before
conducting GWAS on methylation, one of the key questions that
needs to be addressed is how sex influences the genomic
methylation status and how to cope with it in the context of
methylation-disease association study. Methylation can potentially
link to sex and any other phenotypes. As reported by Wu et al. in a
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(MGMT) hypermethylation is more common in squamous cell
carcinomas in males and smokers than in adenocarcinomas in
females, and nonsmokers. MGMT hypermethylation was pro-
nouncedly influenced by sex in addition to smoking status [13].
Such results emphasize the need for a proper way to correct the
sex influence in a methylation-disease study.
In this paper, we use a subsample (n=197, 54 female and 143
male) of a larger genome-wide study, which is designed to
investigate the association between genomic DNA methylation
and alcohol dependence. All participants have some level of
substance abuse, and their substance use behavior was assessed
through questionnaires. Saliva samples were collected from each
participant to extract DNA and then to examine the methylation
value using the Illumina Infinium Methylation Assay. The samples
were processed in a random order, and the subsamples used in this
paper are the first 197 processed samples. We use this data to
investigate the sex effect systemically and also propose a correction
method to eliminate the potentially confounding effect of sex on
methylation-disease association studies. A third-party DNA
methylation data from peripheral blood cells assessed by Illumina
cancer panel array were used to verify the findings.
Results
Five behavioral variables as well as age and sex were used as
phenotypes to investigate the association with methylation status.
The behavioral variables were assessed through self-report
questionnaires, described as follows: 1) The Alcohol Use Disorders
Identification Test (AUDIT) [14]. In this measure, participants
were asked to report the quantity and frequency of heavy drinking
and other symptoms associated with alcohol abuse. The items are
summed to create a total AUDIT score. 2) The Alcohol
Dependence Scale (ADS) [15] includes 24 items with four
subscales. The total score was used as the phenotype in this study.
3) Participants were asked to report the maximum number of
drinks in a single drinking episode (Max_drinks). 4) Self reported
number of cigarettes smoked per day on average (cigarettes use). 5)
The percentage of days smoked marijuana in the past 90 days
(%_MJ_days).
Direct association test on each methylation site with
phenotypes
We first examined the sex influence on methylation via a two-
sample T-test. The results from genomic 20,493 CpG sites spread
out widely, andP-valuesrange from2.84E-80to1.A 5% Bonferroni
multiple comparison corrected false positive rate was used to select
significant sex effects. Thus, 690 CpG sites in 432 genes were
significantly associated with sex (more detailed information see the
supporting Table S1). Among the 432 genes, eleven genes including
12 sites are in autosomes: LRRC2 and TDGF1 in Chromosome 3,
RAB9P1 in chromosome 5, C6ORF68 in Chromosome 6; TLE1 in
Chromosome 9, GLUD1 in Chromosome 10, ALX4 in Chromosome
11, DPPA3 in Chromosome 12, NUPL1 in Chromosome 13,
FLJ20582 and FLJ43276 in Chromosome 15. The remaining 421
genes including 678 sites are located in the X chromosome.
Figure 1A shows methylation values of 12 autosomal sites, while
Figure 1B shows the methylation values of sites in the X
chromosome with red for females and blue for males.
Focusing on the sex influence on autosomes, we found 580
methylation sites (540 genes) in Chromosomes 1 to 22, passing 5%
uncorrected false positive rate. Figure 2A shows the locations of
such sites on chromosomes (see the supporting Table S2 for the full
report), where the top 12 sites passed Bonferroni corrected 5%
false positive. Furthermore, we have identified eight functional
groups prominently presented in these 540 genes. The eight
groups listed in Table 1 were extracted with the highest clustering
stringency, using the built-in gene classification function in the
Database for Annotation, Visualization and Integrated Discovery
(DAVID, http://david.abcc.ncifcrf.gov) bioinformatics resources
[16,17].
We also tested associations between methylation and other
phenotypes using Pearson correlation. Results were corrected by
5% Bonferroni correction. The correlation coefficient for each
phenotype, either significant or not were reported in Table 2 for
complete information. Sex, age, max_drinks, and marihuana use
show very strong connections with methylation level of specific
sites. 85 CpG sites with one in X chromosome were associated
Figure 1. Significant sex effects on 690 methylation sites with
mean and standard deviation values. a): mean and standard
deviation methylation values from 12 autosomal sites. Red indicates
females and blue indicates males. Bars present mean value, while lines
show standard deviation. Eight sites are more methylated in females
than males and four sites are more methylated in males than females.
b): methylation pattern of 678 sites in X chromosome. They are sorted
by female methylation level, presenting 614 sites with higher
methylation in females and 64 sites with higher methylation in males.
Solid squares show mean value while dash lines show standard
deviation.
doi:10.1371/journal.pone.0010028.g001
Sex Effect on Methylation
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marijuana use assessment, and none are from Chromosome X.
Two sites in gene PAGE4 and GRM3 locating in Chromosome X
and 5, respectively, were associated with max_drinks level. One
site in gene SEC31L2 in Chromosome 10 was associated with
cigarette use. The detailed information about the associated
methylation sites were reported in the supporting Table S3.
PCA methylation factors and their association with
phenotypes
Twenty-six factors were extracted from methylation data using
principle component analysis (PCA), maintaining 99% of the data
variance. A factor here represents a combined effect from multiple
methylation sites with various levels of contribution. Two resultant
factors show significant sex differences, with P-values of 2.53E-69
and 1.82E-3 passing 5% Bonferroni correction. These two factors
are also tested for correlation with other phenotypes and results
are listed in Table 3.
ICA methylation factors and their association with
phenotypes
Similarly, 26 independent factors were extracted using inde-
pendent component analysis (ICA), maintaining the same 99% of
variance of data. Only one factor is significantly related to sex with
a P-value of 3.06E-79. The expression of this factor in subjects is
plotted in Figure 3. Females in general have positive expression
weights and males have negative weights except for six subjects
(two males show positive weight values and four females show
negative values). We also tested the correlation of this factor with
other phenotypes in Table 3, and no correlation was found
significant.
In this sex related factor, each site contributes differently with
|Z| score ranging from 83.65 to 0. Z score represents contribution
weight of each site to the factor, with positive/negative sign
showing the direction. Z score distribution reflects the P-value’s
distribution derived in the two-sample T-test on sex. Top sites in
|Z| scores consist of genes in X chromosome and autosomes, such
as TLE1, GLUD1, C6orf68, RAB9P1, TDGF1, FLJ20582, DPPA3,
BXDC1 and LRRC2, which are consistent with the T-test results.
This factor was identified as the sex factor, and we corrected for it
using Equation 4 in Materials and Methods section.
Figure 2. Autosomal sites identified as sex differentially
methylated. Human chromosomes 1-22 are arranged vertically.
Methylation sites in each chromosome are plotted horizontally in blue
line. Red dots present sites showing sex difference based 5%
uncorrected false positive rate. The ones above blue lines are sites
where females are more methylated than males. The ones below blue
lines are sites where males are more methylated than females. a): result
from saliva methylation data. 307 sites are methylated more in females
than in males, while 273 sites are methylated more in males. b): results
from blood cell verification data. 21 sites are methylated more in
females than in males, while 15 sites are methylated more in males.
doi:10.1371/journal.pone.0010028.g002
Table 1. Functional clusters of the autosomal sex differentially methylated genes.
Gene groups Enrichment score Gene List Size Min P-Value
regulation of transcription, DNA-dependent, DNA-binding, nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
2.23 52 1.8E-38
spliceosome, RNA/mRNA splicing, RNA/mRNA processing, RNA–binding 1.7 5 1.7E-09
signal, trans-membrane, membrane, integral to membrane, intrinsic to membrane 1.27 5 7.6E-04
cadherin, cell-cell adhesion, calcium, 1.27 6 5.5E-13
cation channel activity, metal ion transporter activity, channel activity 1.25 7 1.4E-11
G-protein coupled receptor, transducer, rhodopsin-like G-protein coupled receptor, transmembrane
receptor activity
1.03 15 2.5E-19
tyrosine-protein kinase, transmembrane receptor protein tyrosine kinase activity 1.01 5 2.5E-10
protein kinase activity, protein amino acid phosphorylation, protein serine/threonine kinase activity, 0.81 11 1.1E-14
Note: Enrichment score ranks the biological significance of gene groups based on overall modified P-values of all enriched annotation terms.
doi:10.1371/journal.pone.0010028.t001
Sex Effect on Methylation
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10028Association of sex-corrected methylation with
phenotypes
The association result between methylation sites and pheno-
types after the sex effect correction is listed in Table 2. For
maximum drink level and cigarette use, the same associations from
genes PAGE4, GRM6 and SEC31L2 were identified. For marijuana
use, three additional sites from genes TCEAL8, TIMM8A and NOV
demonstrated significant correlations. Two different sites were
associated with age after sex effect correction. The details are
reported in the supporting Table S3.
Verification using an independent cancer panel
methylation data
The verification data are genomic (1298 loci, 762 genes)
methylation values of peripheral blood cell DNA, assessed by
Illumina GoldenGate Methylation Cancer Panel I. The two-
sample T-test on sex difference identified 47 sites in 26 genes
passing 5% Bonferroni correction. Among them, 25 genes are in X
chromosome with one site showing higher methylation in males
than females and others showing the opposite pattern. The P-value
ranges from 1.01E-18 to 2.40E-05. One gene, CASP6 in
Chromosome 4 also presents significant sex difference with female
methylation of 0.0660.02 and male methylation of 0.0160.01 (P-
value: 1.74E-6). Compared with the findings derived from our
saliva methylation data, 22 genes demonstrated significant sex
difference in both saliva samples and peripheral blood cell samples
(see Table S1). Since only 27 sex significantly differentially
methylated genes (5% corrected) in saliva (all in X chromosome)
are included in the Illumina Cancer Panel I array, the overlapping
rate of identified sex affected genes in X chromosome between
saliva and blood cell is 81% (22/27).
Focusing on genes in autosomes, we have identified 36 sites (in
34 genes) showing sex differences by the two-sample T-test of 5%
uncorrected false positive rate. 21 sites show higher methylation in
females than males, and 15 sites show opposite pattern. The
distribution of these 36 sites is plotted in Figure 2B in line with the
results from saliva samples. Four genes, MYLK, HOXA9, PEG10,
and CDKN2B present the same strong sex difference in both saliva
and blood cell DNA methylation. Since a total of 52 genes in the
540 sex strongly differentially methylated autosomal genes (5%
uncorrected) are included in the Illumina Cancer Panel I array,
Table 2. Association test results between methylation and phenotypes.
phenotypes Minimun P-value
Maximum absolute
Correlation
Sites passing 5% Borferroni multple comparison
corretion
Before sex effect correction
Sex 2.84E-80 32.33 (T value) 690 sites
ADS 2.05E-5 0.30 0
AUDIT 1.10E-5 0.31 0
Max_drinks 1.50E-7 0.36 2 sites
Cigarettes 1.20E-6 0.34 1 site
Age 1.32E-16 0.54 85 sites
%_MJ_days 3.78E-07 0.35 8 sites
After sex effect correction
Sex 1.37E-2 2.48 (T value) 0
ADS 2.07E-5 0.30 0
AUDIT 1.09E-5 0.31 0
Max_drinks 2.67E-7 0.36 2 sites (2 sites in common*)
Cigarettes 1.41E-6 0.34 1 site (1 sites in common*)
Age 1.57E-16 0.54 85 sites (83 sites in common*)
%_MJ_days 1.54E-7 0.35 11 sites (8 sites in common*)
*Common sites before and after sex effect correction.
doi:10.1371/journal.pone.0010028.t002
Table 3. Properties of the sex-related factors extracted by PCA and ICA.
Sex ADS AUDIT Max_ drinks Cigarettes Age %_ MJ
PCA: Factor 1 Correlation 27.62* 0.11 0.03 0.08 0.01 0.01 0.11
P-value 2.53E-69 0.12 0.63 0.27 0.93 0.91 0.11
PCA: Factor 2 Correlation 3.16* 0.08 0.14 0.08 0.16 0.11 0.07
P-value 1.82E-3 0.26 0.05 0.28 0.02 0.12 0.34
ICA: Factor 1 Correlation 31.87 0.09 0.00 0.09 0.04 0.03 0.11
P-value 3.06E-79 0.20 0.95 0.21 0.55 0.64 0.13
Note: bold indicates marginal significant correlations passing 5% uncorrected false positive control. * notes for t values from the two-sample T-test.
doi:10.1371/journal.pone.0010028.t003
Sex Effect on Methylation
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methylation is 8% (4/52).
ICA was also performed on the verification data using the same
parameter setting as on the saliva data. Five independent factors were
extracted to keep 99% of the total variance. One factor is significantly
related to sex with a P-value of 1.41E-18. All females show positive
weightsin thisfactor, averaged at0.1860.04. All males show negative
weights averaged at 20.1360.02. After the correction based on the
ICA factor, no methylation site shows a sex difference.
Discussion
Three methods, a direct T-test at each site, PCA and ICA
factorization tests all show strong sex influence in the genome wide
methylation data from saliva, with the minimum P-values of
2.84E-80, 2.53E-69 and 3.06E-79 respectively. We used a 5%
corrected false positive rate to select 690 sites. Their methylation
values in Figure 1 show cases in which methylation is higher in
females than males or vice verse. It suggests that the influence of
sex on methylation is site specific. The presence of more sites with
higher methylation in females than males on the X chromosome
can be explained by the X-inactivation process, in which one of
two copies of genes on the X chromosome in females is silenced.
We do not know any mechanism to explain those X chromosome
sites with higher methylation in males, but they are very interesting
and merit further investigation. In autosomes, our data show a
trend of more sites being highly methylated in females versus
males; i.e. 8 significant sites verse 3 sites in Figure 1A and 307 sites
verse 273 sites in Figure 2A. Fuke et al. discovered subtle but
significantly higher 5-methyldeoxycytidine content in males by a
high performance liquid chromatography (HPLC) study [18]. The
difference, however, might just be caused by different measuring
techniques. HPLC is designed to measure the global methylation
content without knowing/distinguishing individual sites. Micro-
array technique using bisulfite measures for specific sites resulting
in a methylation level for each site.
Our data, overall, show remarkable sex influences on specific
autosomal sites. Genes like TLE1, C6orf68, GLUD1, RAB9P1,
TDGF1, FLG43276, DPPA3, and LRRC2 are the top sex-affected
sites that survived stringent Bonferroni correction. For the 580
autosomal sites in Figure 2A, showing strong yet not quite
statistically significant sex differences (5% uncorrected), may also
reflect true methylation influence from sex. Kaminsky et al.
proposed the hypothesis that sex hormone might induce epigenetic
change, which predisposes female and male differently to un-
Mendelian complex diseases [19]. For example, TLE1,a
transcriptional repressor essential in hematopoesis, neuronal
differentiation and terminal epithelial differentiation, has been
shown to contribute to acute myeloid leukemia (AML), synovial
sarcoma, and other cancers [20,21,22]. Even though the pathways
of TLE1 affecting cancer growth are not clear, our data reflect that
the strong sex difference of TLE1 methylation might explain
partially that AML and synovial sarcoma are a little more
common in males than females. In the total of 540 autosomal sex
differentially affected genes, eight functional groups including
many pathways are involved, from DNA transcription, RNA
splicing, membrane, trans-membrane, cell to cell adhesion, to ion
transporter, etc. It suggests that the influence of sex on methylation
is broad and not limited only to sex specific factors.
In our verification analysis, blood cell DNA showed a pattern of
methylation which was consistent with what we observed for saliva
DNA. Twenty-five genes on the X chromosome and one gene,
CASP6, on Chromosome 4 were identified a significantly sex
difference and the difference occurs in both directions. The
overlapping rate of identified genes with saliva data is 81%. Since
all overlapped genes are from X chromosome, the ratio presents
an attribute of X chromosome between different tissues. When
focusing on autosomes, Figure 2 shows that sex influences
methylation in a very similar way in both saliva and blood cell
DNA (Figure 2A and 2B). Among the 36 autosomal sites showing
clear sex difference (5% uncorrected) in blood cells, 21 are highly
methylated in females and 15 in males. Four genes show the same
sex difference pattern in both saliva and blood cells. The
overlapping rate of 8% might be due to the small number of
samples and tissue differences. Overall, we are more convinced
that sex differences in autosomes may not be statistically
significant, but likely present a true effect of sex.
Both datasets from saliva DNA and blood cell DNA present
genomic sex effects on methylation; a large amount of loci from
both autosomes and X chromosome are affected by sex, and the
influence is in both directions (females highly methylated than
males or vice verse). We notice that between different tissues (or
different populations) the same or different loci can be affected,
but the genomic sex effect pattern holds the same.
Methylation of some genes is possibly modulated by both sex
and other factors, such as age, substance use, and diseases. For
example, in saliva data, methylation status of genes XPNPEP2,
PAGE4, TIMM8A and TCEAL8 is associated with age, cigarette
use and max_drinks, respectively, in addition to sex. Most of the
genes in the verification data are functionally cancer related
including the genes showing sex difference [23,24,25,26] Both
genes CASP6 and HOXA9 are hypermethylated, leading to
decreased gene expression in pancreas cancer tissue [24]. Gene
PEG10 is involved in human hepatocellular carcinogenesis [26].
Gene CDKN2B functionally influences tumor suppression and its
methylation has been studied for its power in leukemia treatment
[25,27,28]. For studies of genetic function or formation of diseases,
the sex influence can potentially obscure the methylation–disease
association results. It is thus important to take into account the sex
confounding effect. There are at least three different ways to
address the sex effect. First, we can use sites only from autosomes.
Such an approach is simple and most likely effective, but some
Figure 3. Weights of the sex-related factor expressed in
subjects. Weights in 143 males are plotted on the left with two
subjects above zeros; weights in 54 females are plotted in the right with
four subjects below zero.
doi:10.1371/journal.pone.0010028.g003
Sex Effect on Methylation
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PAGE4, XPNPEP2, TCEAL8, and TIMM8A from Chromosome X
contribute greatly to non-sex phenotypes. Second, we can try to
remove sites associated with sex only, but that requires a threshold
setting to select sex-related sites. This approach will be subjective
and likely suboptimal. Finally, we can try to correct the sex effect
using factorization methods. Sex factor(s) can encompass both
strong and weak influences on multiple sites, without selecting an
arbitrary cut-off point. Then we can correct the sex effect by
removing the factor(s). PCA and ICA are two such factorization
methods which were compared in this study.
Two factors extracted from the PCA show a significant
association with sex, while ICA extracted only one strong sex
related factor. Since both PCA and ICA maintain the same
amount of variance in the original data, the extracted factors are
representing the same information in a slightly different format.
ICA emphasizes the independence of factors, while PCA only
considers the orthogonality of factors. It is likely that ICA is able to
pull the information of the two PCA sex related factors into one
factor based on the independence criterion. Table 3 also shows
that the sex related factor by ICA is not associated with any other
phenotypes of interest, while the 2
nd factor by PCA shows
marginal connection with AUDIT and cigarette use. This is strong
evidence that suggests we should utilize the sex factor from ICA
not from PCA results, since the correction will not jeopardize the
associations of other known phenotypes. The Z scores of the sex
related factor by ICA displays a similar pattern to P-values of the
T-test on each site. This result provides additional evidence that
the ICA sex factor represents the true sex influence accommodat-
ing both strong to weak effects. Figure 3 displays how the ICA sex
factor is revealed in subjects, with each subject manifesting the sex
factor with an individual expression weight. The sex factor
represents the common sex influence trend extracted from all
subjects, but its expression level allows individual difference. The
weights are clearly clustered into two groups: positive and
negative. Most of the females show positive weights and most of
the males show negative weights. We do not know exactly why six
subjects are showing the opposite pattern, but we hypothesize that
individual endocrinological differences might be involved [19].
ICA is also able to extract one sex related factor from the
verification data, where all females have positive expression
weights and males have negative expression weights.
Sex correction was performed based on the ICA factor, and
Table 2 compares the results of the direct correlation test before
and after the correction. All phenotypes, except sex, show very
similar results. After the correction two different sites out of 85 are
linked to age, and three additional sites are added to be associated
to %_MJ_days. The similarity tells us that sex correction, as
expected, removes effects only from sex and no harm is done for
sex irrelevant sites. More importantly, the fact that more sites show
significant relationships, indicates that sex can be a confounding
factor, influencing association analysis of some methylation sites,
and more accurate associations can be determined after the
correction.
This study focuses on the sex influence on genomic methylation
and correction. Strong evidences from both saliva data and blood
cell verification data show that sex affects methylation both
genome wide and site-specific. A higher methylation in females or
in males can occur, and can occur in autosomes and the X
chromosome. The strong, yet not statistically significant sex
differences in autosomes may truly represent the influence of sex.
Moreover, sex effects can be entangled with other environmental
factors. We proposed a simple method to disentangle and correct
the sex effect. ICA is a data driven method to extract factors based
on high order statistics of data. Given different datasets, e.g.
methylation from different tissues, the sex factor extracted by ICA
can be different in terms of loci and influence strength, but it
should be significantly correlated with sex. Therefore, sex effect
correction is not a fix value correction, instead, adapted to the
data. Confirmation of the significant association with sex is
necessary to identify the sex factor. An alternative approach would
be to simply analyze female subjects and male subjects separately.
This may be a good approach, when the sample size is big enough
to divide into two groups. However, in genome wide studies, we
usually face a situation of large dimensionality and small sample
size, and maximizing sample size in the analysis is always
desirable. Besides, some phenotypes like cancer have different
incidence rates in females and males, and it is important to identify
the underlying mechanisms. The sex factor extracted by ICA and
its expression on each individual provide a direct metric to explain
the sex influence and quantify the influence on each individual. A
sex correction method based on factorization is able to account for
both strong and weak sex effects without drawing a cutoff line,
which is most likely reflecting how sex influences methylation
status on different sites. We have demonstrated that in this study
the sex factor is not related to any other known phenotypes, but
there is the possibility that some unknown trait might contribute to
the observed sex difference, and the correction would negatively
impact the analysis. For such a case, the researcher should
measure the trait first, and test whether it is related to the sex
factor. If not, the correction can proceed. Otherwise, a different
approach should be used. Every methylation site showing a
significant association with any phenotype is of great interest, and
in this study we are just providing a reference point for further
investigation. When we have a relatively small set of interesting
loci, verification by pyrosequencing or a single nucleotide primer
extension based assay will be very helpful.
Materials and Methods
Subjects
One hundred ninety-seven participants including 54 females with
age 32.0261 0 . 7 3a n d1 4 3m a l e sw i t ha g e3 2 . 2 2 69.70 were
investigated in this study, which is a subsample of an on-going study
designed to investigate genetic prediction for substance dependence.
Subjects between age 21 and 55 with a minimum alcohol
consumption of a regular pattern of two binge drinking episodes
per week (allowing comorbidity of tobacco and marijuana use),
otherwise healthy (no history of severe brain injure or brain related
medical problems, no symptoms of psychosis during a diagnostic
interview), were included. The behavioral variables were assessed
through self-report questionnaires during the interview. The samples
were processed in a random order, and the subsamples used in this
paper are the first 197 processed samples, including treatment-
seeking and non-treatment-seeking participants. Participants obtain a
wide range of alcohol use severity (AUDIT range =6–38) in order to
better assessthe relationship between genetics and drinking problems.
The study was conducted according to the principles expressed in the
Declaration of Helsinki, approved by the Institutional Review Board
of University of New Mexico. All patients provided written informed
consent for the collection of samples and subsequent analysis.
Methylation measurement
Participants were instructed to deliver 5 ml of saliva into a
sterile 50 ml conical centrifuge tube. DNA was then extracted
from saliva, purified, bisulfite converted and hybridized. The
Illumina Infinium Methylation Assay was used to detect genome
wide 27,578 CpG sites, spanning 14,495 genes. The CpG sites
Sex Effect on Methylation
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distance to transcription start site ranging from 0 to 1499 bp
averaged at 3896341 bp. A methylation value was outputted for
each site, which is a continuous variable between 0 and 1,
representing the ratio of the intensity of the methy lated type to the
total intensity. Zero means no methylation, and one means 100%
methylation. The reproducibility of Illumina assay methylation is
reported as R
2 of 0.98, and the standard deviation of methylation
values from replicates is less than 0.06 [29]. We observed a very
similar property in our data using two replicates test (R
2=0.97,
SD=0.064). Among the 27,578 CpG sites, some sites have shown
either low level averaged methylation or low level variation among
all 197 subjects. They thus convey very limited information for
further study and great influence of measurement errors. We
eliminated these sites using an empirical threshold setting of
averaged methylation being 5% of maximum value, and/or
variance being 1% of maximum variation. This results in 20,493
CpG sites for further study.
Analyses methods
We use three different ways to test the connection between sex
and genome-wide methylation status, as well as its potential
influence or confounding effects on associations of methylation
with other phenotypes. Furthermore, a sex effect correction
method was introduced based on factorization, and comparisons
before and after the sex effect correction were conducted.
Firstly, a two-sample T-test on sex was performed on each
methylation site, and Pearson correlation was performed to test
association of methylation with other phenotypes. All results are
corrected using 5% Bonferroni multiple comparison correction.
The significant associations and/or the associations with minimum
P-values were listed for each phenotype. When focusing autosome
methylation, we chose 5% uncorrected P-value to identify all
possible sites affected by sex. Then, we grouped these autosomal
sex affected genes based on their functional similarity. DAVID
gene functional classification tool (http://david.abcc.ncifcrf.gov/)
was used due to its ability to provide a rapid means to organize
large lists of genes into functionally related groups to help unravel
the biological content captured by high throughput technologies
[16,17]. Being conservative, we used the highest classification
stringency to extract the most reliable gene groups.
Secondly, PCA, a factorization method, was utilized to extract
factors explaining maximum variance of data. The generic
formula of PCA is presented as [30]:
YT~XT:P~U:S;
XT~U:S:VT, then, P~V;
where U,S,and V are the singule value decomposition results:
ð1Þ
X is the observation data with each row representing a repetition
of the experiment and each column representing a variable or a
dimension. In this study X is the methylation measurement from
each subject. Yis the new representation of data–the latent principle
components/factors. P is the principle component coefficient,
carrying each factor’s expression pattern in subjects. PCA projects
data into new directions so that each direction is orthogonal to each
other. We then test the connection of P with sex and other
phenotypes, aiming at identifying the sex factor.
Similar to PCA, ICA is also used to extract hidden factors in the
data, but through higher order statistics enabling maximization of
the independence of each factor. ICA is generally formed as:
X~A:S; Z~W:X;
if W~A{1,then Z~S;
ð2Þ
max HY ðÞ fg ~{EL n f y Y ðÞ

;
Y~
1
1ze{U ,U~W:XzW0;
where fy Y ðÞ is the probability density function of Y;
Ln is natural logarithm;E is the expected value;
H is the entropy fucntion; W0 is the initial value of W:
ð3Þ
X is an observation data matrix that can be composed of
measurements such as speech signals from multiple microphones,
or subject’s methylation values. S contains the independent
components, which consists of unknown sources such as multiple
speakers’ voices, or methylation factors accounting for various
phenotypes. A is a linear mixing matrix, relating the sources to the
mixed measurements. W is an unmixing matrix. If W equals the
inverse of A, then the Z, the estimated component matrix, is
equivalent to S, the source matrix. Therefore, the essence of ICA is
to find W so that Z is as close as possible to the true independent
components contained in S. There are many ICA algorithms
based on different independence criteria. Among them, the
infomax algorithm attempts to find the W matrix through
maximizing an entropy function as defined in Equation 3
[31,32]. We use infomax to extract factors/components, and then
tested their associations with sex and other phenotypes.
Thirdly, a factor significantly associated with only sex and not
other phenotypes is defined as a sex factor. The effect of this factor is
removed from the observation data using the Equation 4, where sj is
the identified sex factor. The corrected data XC has the same
dimension as X, containing allthe methylation sites corrected for sex.
X~A:S;
A~ a1,a2,...,am ½  ;S~ s1,s2,...,sm ½ 
Xc~X{aj:sj;
where the j is the index for the gender factor,
aj and sj are vectors:
ð4Þ
Finally, the two-sample T-test on sex and Pearson correlation
between methylation and other phenotypes was tested again after
the sex effect correction.
Verification data and methods
To verify the findings of this study, we chose a third-party
independent methylation data (GEO accession: GSE19515), and
conducted the same analysis. The GSE19515 dataset was uploaded
by the German cancer research center, including genomic
methylation data of 27 samples, as well as their sex information. In
this dataset, DNA was prepared from peripheral blood cells of 1
patient (at time of diagnosis and month 27) and 25 healthy controls
(12 males and 13 females). The Ilumina GoldenGate Methylation
Cancer Panel I array was used, spanning 1,505 CpG sites from
promoter regions or the first exon of 808 mostly cancer related genes
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controls data in the verification process. Data quality control was first
applied. Two loci (DAB2IP_P671_F and SCGB3A1_P103_R) from
genes DAB2IP and SCGB3A1 were removed due to their high
averaged detection P-values (.0.5, i.e. targeted signal is lower than
50% of negative control signals). Two hundred and five loci were
removed from analysis due to low level methylation or low variance
(averaged methylation value ,0.01, or averaged variance ,0.0001).
Thus, the verification data include 25 healthy subjects and 1298 loci
(762 genes, 39 of them from X chromosome). Among these 762
genes, 672 genes are included in our saliva DNA methylation data.
We first conducted a two-sample T-test on methylation of each locus
regarding sex difference, and corrected the results with 5%
Bonferroni correction. Then, we used an uncorrected 5% P-value
to select all autosomal loci showing sex differences. Finally, we
performed the ICA analysis to identify the sex related factor. All
results were compared with the corresponding findings from our
saliva data.
Supporting Information
Table S1 960 sites showing significant sex difference on saliva
DNA methylation. 960 sites from autosomes and X chromosome
showing significant sex difference on saliva DNA methylation.
Some also show significant sex difference on peripheral blood cell
DNA methylation.
Found at: doi:10.1371/journal.pone.0010028.s001 (0.45 MB
DOC)
Table S2 580 autosomal sites showing sex difference on saliva
DNA methylation. Some also show sex difference on peripheral
blood cell DNA methylation.
Found at: doi:10.1371/journal.pone.0010028.s002 (0.66 MB
DOC)
Table S3 Correlation results before and after sex effect
correction. Significant correlation of methylation with age,
marijuana use, maximum drink, and cigarette use before and
after sex effect correction.
Found at: doi:10.1371/journal.pone.0010028.s003 (0.14 MB
DOC)
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